血糖モニタリング市場：製品、検査技術、用途、流通チャネル、エンドユーザー別-2025-2030年世界予測

血糖モニタリング市場は、2023年に130億6,000万米ドルと評価され、2024年には140億8,000万米ドルに達すると予測され、CAGR 8.28%で成長し、2030年には228億米ドルになると予測されています。

血糖モニタリング市場の範囲と定義は、個人、特に糖尿病患者のグルコースレベルの測定と追跡に使用されるデバイスと技術に関連します。血糖モニタリングは、糖尿病を管理し、合併症を予防し、全体的な健康を確保するために極めて重要です。主な用途は、糖尿病患者による個人的な使用、診断目的の臨床現場での使用、そして継続的なモニタリングのための使用が増加しています。エンドユーザーは、主に病院、診療所、在宅ケア環境、個人消費者です。この市場を牽引する主な成長要因としては、世界の糖尿病有病率の上昇、糖尿病管理の利点に関する意識の高まり、モニタリング機器の技術的進歩、低侵襲・非侵襲機器へのシフトなどが挙げられます。市場開拓の機会としては、遠隔モニタリングとより正確なデータ分析のためのデジタルヘルスプラットフォームとAIの統合、ウェアラブル技術の開発、糖尿病患者が増加している新興国市場での拡大などが挙げられます。成長に影響を与える限界と課題には、高度なモニタリング機器の高額なコスト、低所得地域におけるヘルスケアへの限られたアクセス、糖尿病の自己管理に関する認識や教育の欠如などがあります。企業は、より費用対効果の高いソリューションの研究に投資し、長寿命のセンサーやデータ解釈のための強化されたソフトウェアなど、患者の利便性と使いやすさに重点を置いた製品を拡大することで、イノベーションを起こすことができると思われます。市場の競争は激しく、技術進歩も著しいため、既存企業も新規参入企業も市場シェア獲得に邁進しています。技術革新の可能性がある分野としては、完全非侵襲的グルコースモニタリング技術の開発、精度の向上とスマートフォンやスマートウォッチとの統合、患者の予後改善に向けたヘルスケアプロバイダーとの協力関係の追求などが挙げられます。個別化された糖尿病管理ソリューションに注力することで、企業は競争優位性を獲得し、個人中心のヘルスケアに向けたトレンドの高まりに沿うことができると思われます。

市場力学：急速に進化する血糖モニタリング市場の主要市場インサイトを公開

血糖モニタリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病の流行と認知度向上プログラム
  • 非侵襲的技術への嗜好の高まり
  • 在宅介護環境における継続的な血糖モニタリングの必要性
• 市場抑制要因
  • 血糖モニタリングシステムのリコール問題
• 市場機会
  • 血糖モニタリングシステムのデザインと機能の進歩
  • 血糖モニタリングに対する償還の強化
• 市場の課題
  • 血糖モニタリングの生産と運用の複雑さ

ポーターのファイブフォース：血糖モニタリング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、血糖モニタリング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血糖モニタリング市場における外部からの影響の把握

外部マクロ環境要因は、血糖モニタリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血糖モニタリング市場における競合情勢の把握

血糖モニタリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血糖モニタリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血糖モニタリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血糖モニタリング市場における成功への道筋を描く

血糖モニタリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病の蔓延と啓発プログラムの改善
    • 非侵襲的血糖モニタリング技術への好感度の高まり
    • 継続的な在宅ケアの必要性
  • 抑制要因
    • 血糖モニタリングシステムの悪影響の想起
  • 機会
    • 血糖モニタリングシステムの設計と機能の進歩
    • 血糖モニタリングの払い戻しの強化
  • 課題
    • 血糖モニタリングの制作と運用の複雑さ
• 市場セグメンテーション分析
  • 製品：自己血糖測定器における個別ガイダンスの提供
  • 試験技術：携帯型・家庭用機器として開発される電極式血糖値モニターの可能性
  • 用途：1型糖尿病の正確性と継続的なモニタリングを備えた高度なCGMの必要性
  • エンドユーザー：病院における臨床効率と患者スループットを最適化する血糖値モニターの提供
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血糖モニタリング市場：製品別

• 持続血糖モニター
  • インスリンポンプ
  • センサー
  • 送信機と受信機
• セルフまたはワンタイムモニター
  • 血糖値測定器
  • ランセット
  • 検査ストリップ

第7章 血糖モニタリング市場テスト技術

• 電極式血糖値モニター
• 光電式血糖値モニター

第8章 血糖モニタリング市場：用途別

• 妊娠糖尿病
• 1型糖尿病
• 2型糖尿病

第9章 血糖モニタリング市場：流通チャネル別

• オフライン
• オンライン

第10章 血糖モニタリング市場：エンドユーザー別

• ホームケア
• 病院・クリニック

第11章 南北アメリカの血糖モニタリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の血糖モニタリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの血糖モニタリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アボット、ビッグフット・バイオメディカルの買収を完了
  • デクスコム、インスリンなしで2型糖尿病を管理できる新しいウェアラブルを発表
  • アステラス製薬とロシュ・ダイアベティス・ケア・ジャパン、ブルースターと提携し統合糖尿病自己管理ソリューションの開発・商品化に向け提携契約を締結
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AdvaCare Pharma
• Advin Health Care
• ARKRAY, Inc.
• Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
• B. Braun Melsungen AG
• BAYER AG
• Becton, Dickinson and Company
• Dexcom, Inc.
• F. Hoffmann-La Roche Ltd.
• GlySens Incorporated
• I-SENS, Inc.
• Insulet Corporation
• Johnson & Johnson Services, Inc.
• LifeScan IP Holding, LLC.
• Medtronic PLC
• Medtrum Technologies Inc.
• Nemaura Medical Inc.
• Nipro Europe Group Companies
• Nova Biomedical
• Novo Nordisk A/s
• NXP Semiconductors N.V.
• PHC Holding Corporation
• Prodigy Diabetes Care LLC
• Sanofi S.A.
• Senseonics Holdings Inc.
• Sinocare Inc.
• Teladoc Health, Inc.
• Terumo Corporation
• Ypsomed AG

LIST OF FIGURES

• FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 55. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 56. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 92. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 93. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 99. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 100. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 106. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 113. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 120. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 127. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 134. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 141. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 148. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 155. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 162. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 175. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 177. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 184. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 191. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 198. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 205. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 212. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 219. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 220. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 222. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 223. ITALY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 225. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 226. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 233. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 238. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 240. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 246. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 247. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 248. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 251. POLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 254. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 255. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 256. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 258. QATAR BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 260. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 261. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 266. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 267. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 268. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 273. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 275. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 276. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 280. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 281. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 282. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 283. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 287. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 288. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 289. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 290. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 294. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 295. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 296. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 297. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 301. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 302. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 303. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 304. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 308. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 309. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2030 (USD MILLION)
• TABLE 310. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2030 (USD MILLION)
• TABLE 311. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 315. UNITED KING

The Blood Glucose Monitoring Market was valued at USD 13.06 billion in 2023, expected to reach USD 14.08 billion in 2024, and is projected to grow at a CAGR of 8.28%, to USD 22.80 billion by 2030.

The scope and definition of the blood glucose monitoring market pertain to devices and technologies used to measure and track glucose levels in individuals, particularly those with diabetes. Blood glucose monitoring is crucial for managing diabetes, preventing complications, and ensuring overall health. Applications primarily include personal use by individuals with diabetes, in clinical settings for diagnostic purposes, and increasingly for continuous monitoring. End-users are predominantly hospitals, clinics, home care settings, and individual consumers. Key growth factors driving this market include the rising prevalence of diabetes globally, increased awareness about the benefits of diabetes management, technological advancements in monitoring devices, and a shift towards minimally invasive and non-invasive devices. Emerging opportunities in the market include the integration of digital health platforms and AI for remote monitoring and more accurate data analytics, wearable technology development, and expansion in emerging markets where diabetes cases are on the rise. Limitations and challenges affecting growth include high costs of advanced monitoring devices, limited access to healthcare in low-income regions, and lack of awareness or education about self-management of diabetes. Companies could innovate by investing in research for more cost-effective solutions and expanding offerings that focus on patient convenience and ease of use, including long-lasting sensors and enhanced software for data interpretation. The nature of the market is highly competitive with rapid technological advances, with both established companies and new entrants striving to capture market share. Areas of potential innovation include developing fully non-invasive glucose monitoring technologies, improving accuracy and integration with smartphones and smartwatches, and pursuing collaboration with healthcare providers for improved patient outcomes. Focusing on personalized diabetes management solutions could offer companies a competitive edge and align with the growing trend towards individual-centric healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Monitoring Market

The Blood Glucose Monitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of diabetes and improved awareness programs
  • Increasing preference for non-invasive blood glucose monitoring technology
  • Need for continuous blood glucose monitoring in-home care settings
• Market Restraints
  • Adverse recalls of blood glucose monitoring systems
• Market Opportunities
  • Advancements in design and capabilities of blood glucose monitoring systems
  • Enhancements in the reimbursements for blood glucose monitoring
• Market Challenges
  • Complexity in the production and operation of blood glucose monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Monitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Monitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Monitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Monitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Monitoring Market

A detailed market share analysis in the Blood Glucose Monitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Monitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Monitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Monitoring Market

A strategic analysis of the Blood Glucose Monitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Continuous Blood Glucose Monitors and Self or One Time Monitors. The Continuous Blood Glucose Monitors is further studied across Insulin Pumps, Sensors, and Transmitter & Receiver. The Self or One Time Monitors is further studied across Blood Glucose Meter, Lancets, and Testing Strips.
• Based on Testing Technology, market is studied across Electrode Type Blood Glucose Monitor and Photoelectric Blood Glucose Monitor.
• Based on Application, market is studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on End-User, market is studied across Home Care and Hospital & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of diabetes and improved awareness programs
    • 5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
    • 5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of blood glucose monitoring systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
    • 5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity in the production and operation of blood glucose monitoring
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
  • 5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
  • 5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
  • 5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Glucose Monitoring Market, by Product

• 6.1. Introduction
• 6.2. Continuous Blood Glucose Monitors
  • 6.2.1. Insulin Pumps
  • 6.2.2. Sensors
  • 6.2.3. Transmitter & Receiver
• 6.3. Self or One Time Monitors
  • 6.3.1. Blood Glucose Meter
  • 6.3.2. Lancets
  • 6.3.3. Testing Strips

7. Blood Glucose Monitoring Market, by Testing Technology

• 7.1. Introduction
• 7.2. Electrode Type Blood Glucose Monitor
• 7.3. Photoelectric Blood Glucose Monitor

8. Blood Glucose Monitoring Market, by Application

• 8.1. Introduction
• 8.2. Gestational Diabetes
• 8.3. Type 1 Diabetes
• 8.4. Type 2 Diabetes

9. Blood Glucose Monitoring Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Offline
• 9.3. Online

10. Blood Glucose Monitoring Market, by End-User

• 10.1. Introduction
• 10.2. Home Care
• 10.3. Hospital & Clinics

11. Americas Blood Glucose Monitoring Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Blood Glucose Monitoring Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Blood Glucose Monitoring Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
  • 14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
  • 14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AdvaCare Pharma
• 3. Advin Health Care
• 4. ARKRAY, Inc.
• 5. Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
• 6. B. Braun Melsungen AG
• 7. BAYER AG
• 8. Becton, Dickinson and Company
• 9. Dexcom, Inc.
• 10. F. Hoffmann-La Roche Ltd.
• 11. GlySens Incorporated
• 12. I-SENS, Inc.
• 13. Insulet Corporation
• 14. Johnson & Johnson Services, Inc.
• 15. LifeScan IP Holding, LLC.
• 16. Medtronic PLC
• 17. Medtrum Technologies Inc.
• 18. Nemaura Medical Inc.
• 19. Nipro Europe Group Companies
• 20. Nova Biomedical
• 21. Novo Nordisk A/s
• 22. NXP Semiconductors N.V.
• 23. PHC Holding Corporation
• 24. Prodigy Diabetes Care LLC
• 25. Sanofi S.A.
• 26. Senseonics Holdings Inc.
• 27. Sinocare Inc.
• 28. Teladoc Health, Inc.
• 29. Terumo Corporation
• 30. Ypsomed AG